The introduction of new agents immunomodulatory drugs (IMiDs) and proteasome inhibitors has brought a major shift in therapeutic paradigm in the treatment of newly diagnosed and refractory ...

Multiple sclerosis (MS) is an autoimmune disease caused by activated autoimmune T lymphocytes in patients resulting in inflammatory demyelination in the central nervous system. A specific therapy ...

Abstract: Drexel’s biomedical engineers and physicians have developed a novel hydrogel-based dressing that protects the wound while keeping it moist and delivers bioactive compounds that correct the ...

GUANGZHOU -- The China-Italy Joint Laboratory of Pharmaceutical Biotechnology and Immunosafety has been launched in South ...

Parkinson's disease is one of the most common diseases affecting the motor and nervous system. It has no treatment yet, and the pathology causes a deterioration of motor skills due to dopaminergic ...

A new study published in the Journal of Neurotrauma shows that intravenous administration of immunomodulatory nanoparticles ...